Clinical efficacy of loratadine combined with mometasone furoate nasal spray in the treatment of allergic rhinitis
Fu Xin
Abstract：Objective To explore the value of loratadine combined with mometasone furoate nasal spray in the treatment of allergic rhinitis,and its impact on clinical symptom improvement time,inflammatory factor level,clinical symptom score,and incidence of adverse events.Methods During the period from April 2021.04 to December 2022.12,a study sample acceptance interval was set.80 patients with allergic rhinitis were treated in our hospital as sample data,and were randomly divided into dynamic groups.The control group included 40 patients(loratadine treatment plan),and the experimental group included 40 patients(loratadine combined with mometasone furoate nasal spray treatment plan);Statistical comparison of the included personnel:(1)improvement time of clinical symptoms;(2)Inflammatory factor levels;(3)Clinical symptom score;(4)Adverse event occurrence rate.Results After the implementation of the treatment method of loratadine combined with mometasone furoate nasal spray,the experimental group showed a significant improvement trend compared to the control group in various research values of patients,(P<0.05).Conclusion In the treatment of allergic rhinitis,the use of loratadine combined with mometasone furoate nasal spray can timely promote the improvement of patients'clinical symptoms,alleviate inflammatory status,improve symptom scores,and have a positive effect.The incidence of adverse events is low.The treatment process is safe and reliable,and has clinical significance for promotion and application.
Keywords：Allergic rhinitisLoratadineMometasone furoate nasal sprayEfficacyImprovement of clinical symptomsInflammation level
Publication Date：2025-01-27
Online Publishing Date：2025-11-27(First online date of this platform, not the publication date of the document)
Pages：3( 42-44 )